In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
作者信息
Rossi J F, Bataille R
出版信息
Br J Cancer. 1984 Jul;50(1):119-21. doi: 10.1038/bjc.1984.147.
Abstract
摘要
相似文献
1
In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.人骨髓瘤浆细胞的体外溶骨活性及骨髓瘤破骨细胞性骨病变的临床评估
Br J Cancer. 1984 Jul;50(1):119-21. doi: 10.1038/bjc.1984.147.
2
Evidence for the secretion of an osteoclast stimulating factor in myeloma.骨髓瘤中破骨细胞刺激因子分泌的证据。
N Engl J Med. 1974 Nov 14;291(20):1041-6. doi: 10.1056/NEJM197411142912001.
3
Update on the pathogenesis of osteolysis in multiple myeloma patients.多发性骨髓瘤患者骨溶解发病机制的最新进展。
Acta Biomed. 2004 Dec;75(3):143-52.
4
Tetany and osteolysis in light chain myeloma with amyloidosis.伴有淀粉样变性的轻链骨髓瘤中的手足搐搦和骨质溶解
Postgrad Med J. 1983 Aug;59(694):527-9. doi: 10.1136/pgmj.59.694.527.
5
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.CCR1和CCR5在多发性骨髓瘤归巢与生长及溶骨性病变发展中的作用：5TMM模型研究
Clin Exp Metastasis. 2006;23(5-6):291-300. doi: 10.1007/s10585-006-9038-6. Epub 2006 Nov 3.
6
Editorial: Osteoclastic bone resorption and the hypercalcemia of cancer.社论：破骨细胞性骨吸收与癌症高钙血症
N Engl J Med. 1974 Nov 14;291(20):1081-2. doi: 10.1056/NEJM197411142912009.
7
The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.白细胞介素-6、白细胞介素-1β和巨噬细胞集落刺激因子在多发性骨髓瘤骨病变发病机制中的关键作用。
Int J Clin Lab Res. 1992;21(4):283-7. doi: 10.1007/BF02591662.
8
An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.一种骨保护素样拟肽可抑制骨髓瘤中的破骨细胞骨吸收和溶骨性骨病。
Cancer Res. 2007 Jan 1;67(1):202-8. doi: 10.1158/0008-5472.CAN-06-1287.
9
[SDF-1/CXCR4 and multiple myeloma osteolytic bone lesions--review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):442-6.
10
New insights in myeloma-induced osteolysis.骨髓瘤诱导性骨溶解的新见解。
Leuk Lymphoma. 2003 Sep;44(9):1463-7. doi: 10.3109/10428190309178765.
引用本文的文献
1
Importance of quantitative histology of bone changes in monoclonal gammopathy.单克隆丙种球蛋白病中骨改变的定量组织学研究的重要性。
Br J Cancer. 1986 Jun;53(6):805-10. doi: 10.1038/bjc.1986.136.
2
Osteosclerotic myeloma with polyneuropathy and hypocalcemia.伴有多神经病和低钙血症的骨硬化性骨髓瘤。
Blut. 1989 Apr;58(4):207-10. doi: 10.1007/BF00320775.
3
Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.新成骨细胞和破骨细胞的募集是人类多发性骨髓瘤发病机制中最早的关键事件。
J Clin Invest. 1991 Jul;88(1):62-6. doi: 10.1172/JCI115305.
本文引用的文献
1
BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.组织培养中的骨吸收。影响对甲状旁腺激素反应的因素。
J Clin Invest. 1965 Jan;44(1):103-16. doi: 10.1172/JCI105117.
2
Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.破骨细胞激活因子产生与多发性骨髓瘤骨病程度的关系。
Br J Haematol. 1981 Jan;47(1):21-30. doi: 10.1111/j.1365-2141.1981.tb02758.x.
3
Localized and indolent myeloma.
Blood. 1980 Sep;56(3):521-5.
4
Quantitative histology of myeloma-induced bone changes.骨髓瘤所致骨改变的定量组织学
Br J Haematol. 1982 Dec;52(4):601-10. doi: 10.1111/j.1365-2141.1982.tb03936.x.
5
Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin.骨髓瘤破骨性骨病变的临床评估：II. 使用鲑鱼降钙素的低钙血症诱发试验。
Metab Bone Dis Relat Res. 1982;4(1):39-42. doi: 10.1016/0221-8747(82)90007-8.
6
Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma.二氯亚甲基二膦酸盐（CI2MDP）对多发性骨髓瘤骨骼病变的长期影响。
Metab Bone Dis Relat Res. 1982;4(3):163-8. doi: 10.1016/0221-8747(82)90013-3.
7
Human bone marrow colony growth in agar-gel.人骨髓在琼脂凝胶中的集落生长。
J Cell Physiol. 1970 Aug;76(1):77-84. doi: 10.1002/jcp.1040760111.
8
Bone-resorbing activity in supernatants from lymphoid cell lines.淋巴细胞系上清液中的骨吸收活性。
N Engl J Med. 1974 Apr 18;290(16):867-71. doi: 10.1056/NEJM197404182901601.
9
Evidence for the secretion of an osteoclast stimulating factor in myeloma.骨髓瘤中破骨细胞刺激因子分泌的证据。
N Engl J Med. 1974 Nov 14;291(20):1041-6. doi: 10.1056/NEJM197411142912001.
10
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.一种多发性骨髓瘤的临床分期系统。测量的骨髓瘤细胞量与初始临床特征、治疗反应及生存情况的相关性。
Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u.
Zotero 插件